Welcome to GTx, Inc., a biopharmaceutical company dedicated to the discovery, development, and commercialization of small molecules for the treatment of cancer, including treatments for breast and prostate cancer, and other serious medical conditions.

Our recognized scientific expertise is in the discovery and development of novel, selective small molecules for the treatment of cancer, cancer supportive care, and other serious medical conditions. Click to learn more about our products in development. More...

GTx Provides Corporate Update Regarding NASDAQ Stock Listing Read More...

GTx Provides Corporate Update and Reports Fourth Quarter and Year-End 2014 Financial Results Read More...

GTx, Inc. to Host Fourth Quarter and Full Year 2014 Financial Results Conference Call and Webcast Read More...